Ocular Therapeutix
OCUL
#4790
Rank
โ‚น210.31 B
Marketcap
โ‚น957.67
Share price
-1.48%
Change (1 day)
-10.79%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2026 (TTM): -โ‚น26.07 Billion

According to Ocular Therapeutix's latest financial reports the company's current earnings are โ‚น52.03 Million. In 2025 the company made an earning of -โ‚น25.5 Billion a decrease over its 2024 earnings that were of -โ‚น18.56 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น26.07 Billion2.25%
2025 -โ‚น25.5 Billion37.43%
2024 -โ‚น18.56 Billion139.68%
2023 -โ‚น7.74 Billion13.65%
2022 -โ‚น6.81 Billion984.05%
2021 -โ‚น0.63 Billion-95.79%
2020 -โ‚น14.92 Billion80.19%
2019 -โ‚น8.28 Billion44.01%
2018 -โ‚น5.75 Billion-5.38%
2017 -โ‚น6.08 Billion41.79%
2016 -โ‚น4.29 Billion12.47%
2015 -โ‚น3.82 Billion38.75%
2014 -โ‚น2.75 Billion115.12%
2013 -โ‚น1.28 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
SurModics
SRDX
-โ‚น1.08 Billion-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
-โ‚น1.18 Billion-95.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
-โ‚น15.47 Billion-44.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
โ‚น15.02 B-153.95%๐Ÿ‡บ๐Ÿ‡ธ USA